Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit. Moderna has filed ...

Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy kids and adults will need to go through placebo-controlled clinical ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

He noted that during the first Trump administration, Trump tried to convince the FDA to release the COVID vaccine 2 months early -- before the 2-month safety followup had been conducted for the ...

This special feature contains summaries of “important opinions” published in Virginia Lawyers Weekly during the first half of ...

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.